Skip to content

Gender-Responsive Treatment for Women Offenders - 1

Gender-Responsive Treatment for Women Offenders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00249613
Enrollment
291
Registered
2005-11-07
Start date
2005-06-30
Completion date
2009-01-31
Last updated
2014-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Abuse Problem

Keywords

gender-responsive substance abuse treatment

Brief summary

The purpose of this study is to determine whether substance abuse treatment designed specifically for drug-dependent women offenders provides better outcomes than standard drug court treatment (mixed-gender programs).

Detailed description

In this five-year study, a total of 300 women entering court-referred treatment throughout Los Angeles County and who agree to participate in the study will be randomly assigned to a women-focused or to a mixed-gender outpatient treatment program. The study will assess the impact of women-focused substance abuse treatment using outcome measures including recidivism, substance abuse and relapse, and social adjustment (e.g., employment, parenting behaviors, psychological improvement, and HIV risk reduction behaviors), compared to the impact of traditional mixed-gender programs. Assessments will occur at baseline and at 1 month, 12 months, and 24 months after admission.

Interventions

BEHAVIORALWomen-Only

Gender-responsive treatment for women only

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of California, Los Angeles
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Drug court participant * At least eighteen (18) years old * Have had no more than three prior non-violent, non-drug felony convictions * Do not have a current charge of driving under the influence of alcohol or drugs or a charge of sale or transportation of drugs

Exclusion criteria

* Not capable of giving informed consent

Design outcomes

Primary

MeasureTime frameDescription
Results (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender Treatmentbaseline and 1-year follow-up
Predictors of Criminal Activity at 12 Months Post Intake12 Months
Any Substance Use Past 30 Days12 MonthsSubstance use in past 30 days at 12 months post intake

Secondary

MeasureTime frameDescription
Predictors of Change in Employment at 12 Months Post Intake: Generalized Estimating Equation (GEE) Model12 month post intakePredictors of change in employment at 12 months post intake: GEE - comparison of Women-Only vs. Mixed-Gender treatment models

Countries

United States

Participant flow

Recruitment details

425 Potential subjects approached at community drug treatment clinics and drug courts 291 Completed baseline intake interview

Pre-assignment details

At baseline, we had 51 Refusals, 30 Ineligible for study 27 No show to baseline interview, and 26 who did not complete baseline intake interview.

Participants by arm

ArmCount
Women-Only Treatment 152 Subjects
Out-patient gender-responsive substance abuse treatment for women only
152
Mixed-Gender Treatment 139 Subjects
Out-patient substance abuse treatment for women and men
139
Total291

Withdrawals & dropouts

PeriodReasonFG000FG001
12 Month Follow-upDeath11
12 Month Follow-upLost to Follow-up108
12 Month Follow-upWithdrawal by Subject66

Baseline characteristics

CharacteristicWomen-Only Treatment 152 SubjectsMixed-Gender Treatment 139 SubjectsTotal
Age, Continuous34.9 years
STANDARD_DEVIATION 10.1
36.5 years
STANDARD_DEVIATION 10.2
35.7 years
STANDARD_DEVIATION 10.2
Region of Enrollment
United States
152 participants139 participants291 participants
Sex: Female, Male
Female
152 Participants139 Participants291 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1520 / 139
serious
Total, serious adverse events
0 / 1520 / 139

Outcome results

Primary

Any Substance Use Past 30 Days

Substance use in past 30 days at 12 months post intake

Time frame: 12 Months

ArmMeasureValue (NUMBER)
Women-OnlyAny Substance Use Past 30 Days0.42 Odds ratio
Comparison: Logistic regression does not separate arms because group status (women-only vs mixed gender) is the dependent variable in our multinomial logistic regression. Because we were not able to randomly assign after all, we also included a propensity score, and additional variables (substance use in past 30 days at baseline, age, race/ethnicity, childhood sexual abuse history, previous treatment, criminal justice funding source, and primary drug) to adjust for the non-random sampling.p-value: 0.0195% CI: [0.22, 0.82]Regression, Logistic
Primary

Predictors of Criminal Activity at 12 Months Post Intake

Time frame: 12 Months

ArmMeasureValue (NUMBER)
Women-OnlyPredictors of Criminal Activity at 12 Months Post Intake0.40 Odds ratio
Comparison: Logistic regression does not separate arms because group status (women-only vs mixed gender) is the dependent variable in our multinomial logistic regression. Because we were not able to randomly assign after all, we also included a propensity score, and additional variables (substance use in past 30 days at baseline, age, race/ethnicity, childhood sexual abuse history, previous treatment, criminal justice funding source, and primary drug) to adjust for the non-random sampling.p-value: 0.0195% CI: [0.21, 0.79]Regression, Logistic
Primary

Results (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender Treatment

Time frame: baseline and 1-year follow-up

Population: Intention to treat (ITT)

ArmMeasureGroupValue (NUMBER)
Women-OnlyResults (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender TreatmentBaseline63.9 Percentage reporting criminal activity
Women-OnlyResults (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender Treatment1 Year Follow-up22.3 Percentage reporting criminal activity
Mixed-GenderResults (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender TreatmentBaseline76.9 Percentage reporting criminal activity
Mixed-GenderResults (Unadjusted) for Criminal Activities in Past 30 Days at Baseline and Follow-up for Women in Women-Only Treatment and Mixed-Gender Treatment1 Year Follow-up39.7 Percentage reporting criminal activity
Secondary

Predictors of Change in Employment at 12 Months Post Intake: Generalized Estimating Equation (GEE) Model

Predictors of change in employment at 12 months post intake: GEE - comparison of Women-Only vs. Mixed-Gender treatment models

Time frame: 12 month post intake

ArmMeasureValue (NUMBER)
Women-OnlyPredictors of Change in Employment at 12 Months Post Intake: Generalized Estimating Equation (GEE) Model-0.70 Beta coefficient
Comparison: Generalized estimating equation (GEE) models do not separate arms: group status (women-only vs mixed-gender) is the dependent variable. Because we were not able to randomly assign, we also included a propensity score, and additional variables (education, race/ethnicity, marital status, income, history of sexual abuse, criminal justice funding source, had child, mental health symptoms, and a time in treatment by group interaction term) to adjust for the non-random sampling.p-value: 0.3395% CI: [-2.11, 0.7]Generalized estimating equations (GEE)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026